PRESBYOPIA THERAPIES, INC.

Profile

Company Names

PRESBYOPIA THERAPIES, INC.
LENZ THERAPEUTICS, INC.
PRESBYOPIA THERAPIES, LLC

Addresses

445 MARINE VIEW AVE., SUITE #320, DEL MAR, CA 92014

915 OCEAN BOULEVARD, CORONADO, CA 92118

915 OCEAN BLVD., CORONADO, CA 92118

Phone Numbers

619-890-5125
(619) 890-5125

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$136,152,298.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2023-03-06 
$83,499,961.00 
$83,499,961.00 
$0.00 
Equity 
3
2020-10-30 
$49,002,348.00 
$49,002,348.00 
$0.00 
Equity 
2
2020-08-05 
$250,000.00 
$250,000.00 
$0.00 
Debt 
1
2016-06-03 
$3,399,989.00 
$3,400,000.00 
$11.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRIS 
 
DIMITROPOULOS 
DIRECTOR
APNIMED, INC.   |  LENZ THERAPEUTICS, INC.   |  BIOLINQ INC   |  ALTO NEUROSCIENCE, INC.   |  HISTOSONICS, INC.
FRED 
 
GUERARD 
DIRECTOR
LENZ THERAPEUTICS, INC.
FREDERIC 
 
GUERARD 
DIRECTOR
GRAYBUG VISION, INC.   |  LENZ THERAPEUTICS, INC.   |  CALCIMEDICA, INC.   |  SPIRAL THERAPEUTICS INC   |  QLARIS BIO, INC.
GERALD 
 
HORN 
EXECUTIVE OFFICER, DIRECTOR
PRESBYOPIA THERAPIES, LLC   |  PRESBYOPIA THERAPIES, INC.
STEFAN 
 
LARSON 
DIRECTOR
TORNADO MEDICAL SYSTEMS, INC.   |  CLEARMRI SOLUTIONS LTD.   |  TURNSTONE BIOLOGICS CORP.   |  APNIMED, INC.   |  LENZ THERAPEUTICS, INC.
MARK 
 
LESTER 
EXECUTIVE OFFICER, DIRECTOR
PASSPORT SYSTEMS INC   |  EVENT FARM, INC.   |  PRESBYOPIA THERAPIES, LLC   |  TEXAS HEALTH SURGERY CENTER ROCKWALL, LLC   |  TWINE HEALTH, INC.   |  PRESBYOPIA THERAPIES, INC.   |  PHANTOM SPACE CORP
JAMES 
 
MCCOLLUM 
EXECUTIVE OFFICER, DIRECTOR
POWERVISION, INC.   |  RESTORATION ROBOTICS INC   |  PRESBYOPIA THERAPIES, LLC   |  MIVI NEUROSCIENCE, INC.   |  LENZ THERAPEUTICS, INC.
JAMES 
W. 
MCCOLLUM 
EXECUTIVE OFFICER, DIRECTOR
PRESBYOPIA THERAPIES, LLC   |  PRESBYOPIA THERAPIES, INC.
CLARE 
 
OZAWA 
DIRECTOR
INCEPTION IBD, INC.   |  MISTRAL THERAPEUTICS, INC.   |  VERSANT VENTURE CAPITAL VII, L.P.   |  OYSTER POINT PHARMA, INC.   |  858 THERAPEUTICS, INC.   |  LYCIA THERAPEUTICS, INC.   |  JENGU THERAPEUTICS, INC.   |  VERSANT VANTAGE II, L.P.   |  VERSANT VOYAGEURS II, L.P.   |  VERSANT VOYAGEURS II (CANADA), L.P.   |  VERSANT VENTURE CAPITAL VIII, L.P.   |  VERSANT VENTURE CAPITAL VIII (CANADA), L.P.   |  MARCH THERAPEUTICS, INC.   |  LENZ THERAPEUTICS, INC.   |  VERSANT VOYAGEURS III, L.P.   |  VERSANT VOYAGEURS III (CANADA), L.P.   |  VERSANT VANTAGE III, L.P.   |  VERSANT VANTAGE III (CANADA), L.P.   |  VERSANT VENTURE CAPITAL IX, L.P.   |  VERSANT VENTURE CAPITAL IX (CANADA), L.P.   |  VERSANT VENTURE CAPITAL SPV I (SAB), L.P.
ZACH 
 
SCHEINER 
DIRECTOR
ADAGIO MEDICAL, INC.   |  LENZ THERAPEUTICS, INC.   |  SPYGLASSPHARMA, INC.   |  SYDNEXIS, INC.   |  EXO IMAGING, INC.   |  SPARROW PHARMACEUTICALS, INC.   |  MEMENTO MEDICINES, INC.
EVERT 
 
SCHIMMELPENNINK 
EXECUTIVE OFFICER, DIRECTOR
LENZ THERAPEUTICS, INC.   |  IBIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-03-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-06 
2022-11-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-30 
2020-11-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-30 
2020-09-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2020-08-05 
2016-06-30
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2016-06-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#